Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-017324
Filing Date
2017-08-11
Accepted
2017-08-11 08:31:15
Documents
50
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q novn-10q_20170630.htm 10-Q 1222207
2 EX-10.4 novn-ex104_173.htm EX-10.4 20828
3 EX-10.5 novn-ex105_570.htm EX-10.5 6380
4 EX-31.1 novn-ex311_9.htm EX-31.1 15473
5 EX-31.2 novn-ex312_6.htm EX-31.2 15569
6 EX-32.1 novn-ex321_7.htm EX-32.1 11400
7 EX-32.2 novn-ex322_11.htm EX-32.2 11394
  Complete submission text file 0001564590-17-017324.txt   3849436

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT novn-20170630.xml EX-101.INS 620743
9 XBRL TAXONOMY EXTENSION SCHEMA novn-20170630.xsd EX-101.SCH 35658
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE novn-20170630_cal.xml EX-101.CAL 33868
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE novn-20170630_def.xml EX-101.DEF 79333
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE novn-20170630_lab.xml EX-101.LAB 258254
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE novn-20170630_pre.xml EX-101.PRE 183597
Mailing Address 4105 HOPSON ROAD MORRISVILLE NC 27560
Business Address 4105 HOPSON ROAD MORRISVILLE NC 27560 919-485-8080
Novan, Inc. (Filer) CIK: 0001467154 (see all company filings)

EIN.: 204427682 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37880 | Film No.: 171023044
SIC: 2834 Pharmaceutical Preparations